All Stories

  1. Co-production in clinical practice: a case-study of engagement with patients with dementia and Huntington's disease to develop meaningful cognitive activities

    Article • Journal of Enabling Technologies, September 2023, Emerald

    Kieran Breen

  2. Predicting clozapine dose required to achieve a therapeutic plasma concentration – A comparison of a population algorithm and three algorithms based on gene variant models

    Article • Journal of Psychopharmacology, September 2023, SAGE Publications

    Kieran Breen

  3. The use of video remote interpreting (VRI) in a medium secure psychiatric setting during the COVID-19 lockdown

    Article • Journal of Forensic Practice, July 2023, Emerald

    Kieran Breen

  4. Staff perceptions of patient inequalities in a UK secure mental healthcare setting

    Article • Equality Diversity and Inclusion An International Journal, April 2023, Emerald

    Kieran Breen

  5. “It’s the discharge and what comes after that” – a phenomenological analysis of peer support workers’ lived experiences of transitioning from psychiatric care

    Article • Journal of Forensic Practice, March 2023, Emerald

    Kieran Breen

  6. Behavioural, medical & environmental interventions to improve sleep quality for mental health inpatients in secure settings: a systematic review & meta-analysis

    Article • Journal of Forensic Psychiatry and Psychology, August 2022, Taylor & Francis

    Kieran Breen

  7. Differences in body mass index trajectories of adolescent psychiatric inpatients by sex, age, diagnosis and medication: an exploratory longitudinal, mixed effects analysis

    Article • Child and Adolescent Mental Health, July 2022, Wiley

    Kieran Breen

  8. The experience of inequality and its impact on mental illness – thematic analysis of patients’ lived experiences admitted to secure mental health hospital

    Article • Journal of Forensic Practice, May 2022, Emerald

    Kieran Breen

  9. Sleep quality and adverse incidents in secure mental health settings

    Article • Journal of Forensic Psychiatry and Psychology, May 2022, Taylor & Francis

    Kieran Breen

  10. A new era in psychiatry: the impacts of COVID-19 and the shift to telepsychiatry on clinical practice and clinician well-being

    Article • Journal of Enabling Technologies, April 2022, Emerald

    Kieran Breen

  11. The impact of inequality on mental illness: thematic analysis on clinical notes

    Article • Journal of Forensic Practice, September 2021, Emerald

    Kieran Breen

  12. Inequalities in women’s medium or low secure mental health settings: a scoping review

    Article • Journal of Forensic Practice, September 2021, Emerald

    Kieran Breen

  13. Physical activity for adolescents with severe mental illness: a systematic scoping review

    Article • International Review of Sport and Exercise Psychology, October 2020, Taylor & Francis

    Kieran Breen

  14. Adolescent inpatient completers of dialectical behaviour therapy

    Article • Journal of Forensic Practice, December 2019, Emerald

    Kieran Breen

  15. Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1

    Article • Journal of Parkinson s Disease, September 2015, IOS Press

    Kieran Breen

  16. What impacts on the stress symptoms of Parkinson’s carers? Results from the Parkinson’s UK Members’ Survey

    Article • Disability and Rehabilitation, April 2013, Taylor & Francis

    Kieran Breen

  17. Non-motor symptoms of Parkinson’s disease: the patient’s perspective

    Article • Journal of Neural Transmission, December 2012, Springer Science + Business Media

    Kieran Breen

  18. Nicotine modifies in vivo and in vitro rat hippocampal amyloid precursor protein processing in young but not old rats

    Article • Neuroscience Letters, April 2012, Elsevier

    Kieran Breen

  19. Parkinson's U.K.: Pushing the search for a cure to new levels

    Article • Stem Cells, March 2012, Oxford University Press (OUP)

    Kieran Breen

  20. Helicobacter pylori eradication for Parkinson's disease

    Article • Cochrane Database of Systematic Reviews, November 2011, Wiley

    Kieran Breen

  21. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies

    Article • Cochrane Database of Systematic Reviews, November 2011, Wiley

    Kieran Breen

  22. Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials

    Article • Cochrane Database of Systematic Reviews, November 2011, Wiley

    Kieran Breen

  23. Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland

    Article • Movement Disorders, December 2009, Wiley

    Kieran Breen

  24. Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau

    Article • Journal of Neurochemistry, August 2008, Wiley

    Dr Jonathan Paul Fry, Kieran Breen

  25. The effect of stress on the expression of the amyloid precursor protein in rat brain

    Article • Neuroscience Letters, February 2008, Elsevier

    Kieran Breen

  26. The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study

    Article • Movement Disorders, October 2007, Wiley

    Kieran Breen

  27. The amyloidogenic potential and behavioral correlates of stress

    Article • Molecular Psychiatry, October 2007, Springer Science + Business Media

    Kieran Breen

  28. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients

    Article • Movement Disorders, June 2007, Wiley

    Kieran Breen

  29. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis

    Article • Journal of Neurology Neurosurgery & Psychiatry, October 2006, BMJ

    Kieran Breen

  30. Article • BMC Structural Biology, January 2006, Springer Science + Business Media

    Kieran Breen

  31. Lipopolysaccharide stimulates the secretion of the amyloid precursor protein via a protein kinase C-mediated pathway

    Article • Neurobiology of Disease, August 2005, Elsevier

    Kieran Breen

  32. The effects of chronic nicotine on spatial learning and bromodeoxyuridine incorporation into the dentate gyrus of the rat

    Article • Psychopharmacology, July 2005, Springer Science + Business Media

    Kieran Breen

  33. Axonal transport of the cellular prion protein is increased during axon regeneration

    Article • Journal of Neurochemistry, February 2005, Wiley

    Kieran Breen

  34. Inducible form of nitric oxide synthase expression in rat cortical neuronal cells in vitro

    Article • Neurobiology of Disease, October 2004, Elsevier

    Kieran Breen

  35. Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors

    Article • Clinical Biochemistry, February 2004, Elsevier

    Kieran Breen

  36. The dynamic localization of the glucocorticoid receptor in rat C6 glioma cell mitochondria

    Article • Molecular and Cellular Endocrinology, November 2003, Elsevier

    Kieran Breen

  37. The role of protein phosphorylation in α2,6(N)-sialyltransferase activity

    Article • Biochemical and Biophysical Research Communications, September 2003, Elsevier

    Kieran Breen

  38. The over-expression of the wild type or mutant forms of the presenilin-1 protein alters glycoprotein processing in a human neuroblastoma cell line

    Article • Neuroscience Letters, July 2003, Elsevier

    Kieran Breen

  39. The role of protein glycosylation in the control of cellular N‐sialyltransferase activity

    Article • FEBS Letters, April 2002, Wiley

    Kieran Breen

  40. Activation of phospholipase D by metabotropic glutamate receptor agonists in rat cerebrocortical synaptosomes

    Article • British Journal of Pharmacology, November 2000, Wiley

    Kieran Breen

  41. Factors influencing the processing and function of the amyloid β precursor protein—a potential therapeutic target in Alzheimer's disease?

    Article • Pharmacology & Therapeutics, May 2000, Elsevier

    Kieran Breen

  42. Prenatal exposure to SKF-38393 alters the response to light of adult rats

    Article • Neuroreport, May 2000, Wolters Kluwer Health

    Kieran Breen

  43. Article • Glycoconjugate Journal, January 2000, Springer Science + Business Media

    Kieran Breen

  44. Overexpression of the α2,6 (N) sialyltransferase enzyme in human and rat neural cell lines is associated with increased expression of the polysialic acid epitope

    Article • Journal of Neuroscience Research, November 1999, Wiley

    Kieran Breen

  45. The effect of corticosteroids on amyloid β precursor protein/amyloid precursor-like protein expression and processing in vivo

    Article • Neuroscience Letters, November 1999, Elsevier

    Kieran Breen

  46. Modest cholinergic deafferentation fails to alter hippocampal G-proteins

    Article • Neurochemistry International, July 1999, Elsevier

    Kieran Breen

  47. The role of the protein glycosylation state in the control of cellular transport of the amyloid β precursor protein

    Article • Neuroscience, February 1999, Elsevier

    Kieran Breen

  48. Article • Glycoconjugate Journal, January 1999, Springer Science + Business Media

    Kieran Breen

  49. Protein Kinase C Activation Potentiates the Rapid Secretion of the Amyloid Precursor Protein from Rat Cortical Synaptosomes

    Article • Journal of Neurochemistry, January 1999, Wiley

    Kieran Breen

  50. Stimulation of Sialyltransferase by Subchronic Low-Level Lead Exposure in the Developing Nervous System

    Article • Toxicology and Applied Pharmacology, July 1998, Elsevier

    Kieran Breen

  51. The role of glycoproteins in neural development, function, and disease

    Article • Molecular Neurobiology, April 1998, Springer Science + Business Media

    Kieran Breen

  52. Glucocorticoid induction of the α2,6 sialyltransferase enzyme in a mouse neural cell line

    Article • Journal of Neuroscience Research, March 1998, Wiley

    Kieran Breen

  53. Glucocorticoid induction of the ?2,6 sialyltransferase enzyme in a mouse neural cell line

    Article • Journal of Neuroscience Research, March 1998, Wiley

    Kieran Breen

  54. The effect of corticosteroids on serum sialyltransferase enzyme activities in the rat

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, January 1998, Elsevier

    Kieran Breen

  55. The interaction between chronic low-level lead and the amyloid β precursor protein

    Article • Amyloid, January 1998, Taylor & Francis

    Kieran Breen

  56. Article • Glycoconjugate Journal, January 1998, Springer Science + Business Media

    Kieran Breen

  57. The biochemical consequences of α2,6(N) sialyltransferase induction by dexamethasone on sialoglycoprotein expression in the rat H411e hepatoma cell line

    Article • FEBS Letters, August 1997, Wiley

    Kieran Breen

  58. Individual isoforms of the amyloid ?precursor protein demonstrate differential adhesive potentials to constituents of the extracellular matrix

    Article • Journal of Neuroscience Research, July 1997, Wiley

    Kieran Breen

  59. Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function

    Article • Biological Psychiatry, June 1997, Elsevier

    Kieran Breen

  60. Evidence for a correlation between ambient cholesterol levels and soluble plasma sialyltransferase enzyme activity

    Article • Glycoconjugate Journal, August 1996, Springer Science + Business Media

    Kieran Breen

  61. The expression of neural cell sialoglycoproteins following glucocorticoid regulation of sialyltransferase activity in vivo

    Article • Cellular and Molecular Neurobiology, June 1996, Springer Science + Business Media

    Kieran Breen

  62. Tissue-specific regulation of sialyltransferase activities in the rat by corticosteroids in vivo

    Article • Glycobiology, January 1996, Oxford University Press (OUP)

    Kieran Breen

  63. The control of sialyltransferase activity in tumor‐cell lines derived from different tissues is multifactorial

    Article • FEBS Letters, August 1995, Wiley

    Kieran Breen

  64. A Decrease in Neural Sialyltransferase Activity in Alzheimer’s Disease

    Article • Dementia and Geriatric Cognitive Disorders, January 1995, Karger Publishers

    Kieran Breen

  65. Heparin induction of the β-amyloid precursor protein (AβPP) in a neural cell line is regulated by cell confluency state

    Article • Amyloid, January 1995, Taylor & Francis

    Kieran Breen

  66. Glucocorticoid potentiation of lead neurotoxicity in the mouse HN9 hippocampal cell line

    Article • Toxicology in Vitro, June 1994, Elsevier

    Kieran Breen

  67. Increase in extracellular NCAM and amyloid precursor protein following induction of long-term potentiation in the dentate gyrus of anaesthetized rats

    Article • Neuroscience Letters, March 1994, Elsevier

    Kieran Breen

  68. A decrease in serum sialyltransferase levels in Alzheimer's disease

    Article • Neurobiology of Aging, January 1994, Elsevier

    Kieran Breen

  69. APP-collagen interaction is mediated by a heparin bridge mechanism

    Article • Molecular and Chemical Neuropathology, February 1992, Springer Science + Business Media

    Kieran Breen

  70. Beta amyloid precursor protein mediates neuronal cell‐cell and cell‐surface adhesion

    Article • Journal of Neuroscience Research, January 1991, Wiley

    Kieran Breen

  71. Intraventricular infusions of antibodies to amyloid-β-protein precursor impair the acquisition of a passive avoidance response in the rat

    Article • Neuroscience Letters, July 1990, Elsevier

    Kieran Breen

  72. Cyclic AMP-dependent expression of the heavy neurofilament (NF-H) polypeptide in differentiating neuroblastoma cells

    Article • Molecular Brain Research, February 1990, Elsevier

    Kieran Breen

  73. The developmental regulation of the L2/HNK‐1 and L3 carbohydrate epitopes in mouse brain Evidence for separate control of lipid‐ and protein‐bound epitopes

    Article • FEBS Letters, April 1989, Wiley

    Kieran Breen

  74. Partial sequence of the rat heavy neurofilament polypeptide (NF‐H) Identification of putative phosphorylation sites

    Article • FEBS Letters, December 1988, Wiley

    Kieran Breen

  75. Soluble rat brain sialidase does not influence intracellular glycosylation of Golgi sialyltransferase or its constitutive glycoproteins

    Article • Neuroscience Letters, June 1988, Elsevier

    Kieran Breen

  76. Lead stimulates Golgi sialyltransferase at times coincident with the embryonic to adult conversion of the neural cell adhesion molecule (N-CAM)

    Article • Toxicology, April 1988, Elsevier

    Kieran Breen

  77. Differentiation‐Dependent Sialylation of Individual Neural Cell Adhesion Molecule Polypeptides During Postnatal Development

    Article • Journal of Neurochemistry, March 1988, Wiley

    Kieran Breen

  78. Perturbations of cellular functions integral to neural tube formation by the putative teratogen sodium valproate

    Article • Toxicology in Vitro, January 1988, Elsevier

    Kieran Breen

  79. Postnatal D2‐CAM/N‐CAM Sialylation State Is Controlled by a Developmentally Regulated Golgi Sialyltransferase

    Article • Journal of Neurochemistry, May 1987, Wiley

    Kieran Breen